Psychiatrists will gain timely, clinically relevant, and practice-based updates in a panoramic in-person setting.
This full-day meeting will provide engaging sessions led by reputed thought leaders in each of schizophrenia, postpartum depression, and major depressive disorder, ADHD, and addiction. A patient perspective will be shared as part of each program to ensure clinicians gain practical, real-world insight.
Register NowSubscribe
Earn up to 5.0 AMA PRA Category 1 Credits™
Keynote Speaker
Dani Donovan
ADHD Storytelling: Bridging the Gap Between Clinical Knowledge & Lived Experience
Purpose-driven creator, author, and ADHD advocate.
Dani Donovan is a purpose-driven creator, author, and ADHD advocate whose cathartic comics, TikTok videos, and #NeurodiverseSquad hashtag have helped build an online community for adults living with ADHD. She’s been featured in publications like The New York Times, BBC News, and NPR, and was the closing keynote at the 2021 International ADHD Conference. Her unorthodox self-help book, The Anti-Planner: How to Get Sh*t Done When You Don’t Feel Like It, offers creative strategies, activities, and games to help procrastinators understand their emotions and overcome productivity roadblocks. Dani’s work has encouraged thousands of people to seek diagnosis and treatment. Explore her content at ADHDDD.com or follow her on social media (@danidonovan).
Disclosure: Ms. Donovan has received consulting fees from Edelman (Takeda) and ADHD Online, and has received other financial or material support from RevHealth as a freelance illustrator and BetterHelp as a freelance author.
Faculty
Kristina M. Deligiannidis, MD
Professor, Psychiatry, Obstetrics & Gynecology and Molecular Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Michael Thase, MD
Professor of Psychiatry
Perlman School of Medicine University of Pennsylvania
Leslie Citrome, MD, MPH
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Ayana Jordan, MD, PhD
Barbara Wilson Associate Professor of Psychiatry
Associate Professor, Department of Population Health
Rubiahna L. Vaughn, MD, MPH
Assistant Professor, Department of Psychiatry and Behavioral Sciences
Albert Einstein College of Medicine
Jonathan M. Meyer, MD
Voluntary Clinical Professor, Department of Psychiatry
University of California, San Diego
Bethany Yeiser
Patient Perspective, Schizophrenia
Jeffrey Newcorn, MD
Professor of Psychiatry and Pediatrics
Icahn School of Medicine at Mount Sinai
RESERVE YOUR SEAT TODAY!Space is limited
Agenda
8:00 AM - 8:30 AM
Welcome and Registration
8:30 AM - 9:15 AM
Keynote Speaker: Dani Donovan
9:25 AM - 10:25 AM
Session I: Expanding the Clinician Toolbox with Novel ADHD Treatment Options
Learning Objectives:
- Investigate challenges in misdiagnosis and identify tools for proper ADHD diagnosis
- Examine the efficacy, safety, formulation, and pharmacokinetics of novel drug delivery systems for ADHD management
- Optimize treatment of ADHD with a multimodal/multidisciplinary approach
CME Institute Showcase in The Journal of Clinical Psychiatry
Jeffrey Newcorn, MD
10:35 AM - 11:35 AM
Session II: Reviewing Non-Dopaminergic Pathways for Positive and Negative Schizophrenia Symptom Management
Learning Objectives
- Articulate side effect development and negative symptom control challenges associated with standard of care antipsychotics
- Review the latest research describing the biologic rationale of novel non-dopaminergic pathways in schizophrenia
- Examine emerging clinical trial data for non-dopamine-targeting schizophrenia therapies
Supported by an educational grant from Sunovion Pharmaceuticals, Inc. and Otsuka America Pharmaceutical, Inc.
CME Institute Showcase in The Journal of Clinical Psychiatry
Leslie Citrome, MD, MPH
Jonathan M. Meyer, MD
Bethany Yeiser
11:35 AM - 12:30 PM
Break – Lunch provided
12:35 PM - 1:35 PM
Session III: Staying Up to Date with Evolving Postpartum Depression Pathophysiology and Treatment Research
Learning Objectives
- Examine the impact of delayed diagnosis on outcomes in PPD and best practices for screening
- Explore pathophysiological mechanisms related to the expression of PPD symptoms
- Review clinical trial safety, efficacy, and dosing for current and emerging therapeutics for PPD
Supported by an educational grant from Sage Therapeutics, Inc.
Kristina M. Deligiannidis, MD
Rubiahna L. Vaughn, MD, MPH
1:45 PM - 2:45 PM
Session IV: Addiction Psychiatry
Learning Objectives
- Screening Brief Intervention and Referral to Treatment (SBIRT)
- Medications for Addiction Treatment with focus on Medications for Opioid Use Disorder (MOUD)
- Late breaking research (e.g., psilocybin to treat mental health and addiction)
CME Institute Showcase in The Journal of Clinical Psychiatry
Ayana Jordan, MD, PhD
2:45 PM - 3:00 PM
Break
3:00 PM - 4:00 PM
Session V: Unmet Needs in the Pharmacotherapy of Depression: Is Help Really on the Way?
Learning Objectives:
- Describe the unmet needs that are not well addressed by the current state of the art for antidepressant pharmacotherapy
- State the recent developments that have led to new medications that address these problems
- Identify treatments that target glutamatergic mechanisms, such as ketamine/esketamine and neurosteroids that indirectly modulate glutamatergic neurotransmission
Michael Thase, MD
4:00 PM - 6:00 PM
Reception on the 21st Floor
The Venue
The Glasshouse in Chelsea is a modern and idyllic space that makes an optimal learning environment. The Glasshouse features full-light, floor-to-ceiling windows with panoramic views of the city with an accessible balcony.
Emerging Perspectives in Psychiatry CME sessions will take place on the 14th floor, while lunch, breaks, and a reception will take place on the 21st floor.
545 W 25th Street, 21st Floor
New York, NY 10001
Click to See Map
RESERVE YOUR SEAT TODAY!Space is limited
Reserve Your Seat Today!
All proceeds will support the National Alliance on Mental Illness
Earn up to 5.0 AMA PRA Category 1 Credits™